CIMOF (Centre d'Imagerie MOléculaire et Fonctionnelle)

What CIMOF (Centre d'Imagerie MOléculaire et Fonctionnelle) does

CIMOF (Centre d'Imagerie Moléculaire et Fonctionnelle) is a French nuclear medicine diagnostic imaging center headquartered in Toulouse, founded in 1988 and operating across five clinical sites in the Occitanie and Pyrénées-Atlantiques regions. The company delivers two core service lines: PET (TEP) scans and scintigraphy examinations, supported by state-of-the-art capital equipment including a GE Digital PET CT scanner, two D-SPECT Spectrum Dynamics cardiac imaging systems, and two hybrid gamma cameras (GE 870 DR and 870 CZT). Its radiotracer portfolio spans FDG, Choline, PSMA, F-DOPA, and DOTATOC, enabling applications in oncology (including prostate cancer staging via PSMA and neuroendocrine tumor imaging via F-DOPA/DOTATOC), cardiology, neurology, orthopedics, endocrinology, and renal diagnostics.

The business model is a professional-services revenue stream generated from diagnostic imaging procedures, reimbursed predominantly through the French Sécurité Sociale national health insurance system. Patient acquisition is driven by physician referrals and direct appointment booking via the Venusshare online portal, with results delivered through dedicated patient and physician portals. Distribution runs through embedded host-facility partnerships — Clinique Pasteur (Toulouse), Clinique des Cèdres (Cornebarrieu), Clinique du Pont de Chaume (Montauban), IUCT Oncopole (Toulouse), and Centre Hospitalier de Pau — and through the GCS Pyrénées TEP cooperation group, which jointly operates PET infrastructure with Centre Hospitalier de Tarbes-Lourdes.

CIMOF is privately held with no public listing and no disclosed investor or funding history. The company is in an active capacity-expansion phase as of 2024, including the installation of a second PET CT scanner at Clinique Pasteur, the deployment of a second scanner at Centre Hospitalier de Pau via the GCS partnership, and open recruitment for medical radiology manipulators and secretarial staff. It employs approximately 15 staff and positions itself as one of the principal nuclear medicine providers in the Occitanie region.

Name

CIMOF (Centre d'Imagerie MOléculaire et Fonctionnelle)

Legal name

Centre d'Imagerie Moléculaire et Fonctionnelle (CIMOF)

Website

https://tep-toulouse.fr

Company type

Private

Founded year

1988

Operating status

Operating

Headcount range

11–50 employees

Short description

CIMOF is a French nuclear medicine imaging center founded in 1988 in Toulouse, operating five clinical sites across the Occitanie region. It delivers PET scans and scintigraphy examinations for oncology, cardiology, neurology, and other specialties to physician-referred patients, reimbursed primarily through the Sécurité Sociale.

Ownership category

akta.pro rank

Product category

Diagnostic Imaging Services

NAICS

Diagnostic Imaging Centers (621512), Medical and Diagnostic Laboratories (62151)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Medical Laboratories (8071)

akta.pro primary industry

Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology) (HLAFAKAB)

akta.pro secondary industry

Nuclear Medicine Clinical Services & Therapy Centers (HLAIAGAI)

Keywords

• Nuclear medicine imaging
• PET scan diagnostics
• Scintigraphy examinations
• Molecular imaging services
• Radiotracer diagnostics

Headquarters

HQ city

Toulouse

HQ country

France

HQ region

Europe

Offices5 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Infrastructure, Technology or R&D, Operations, Supply Chain

Revenue model

1. Medical Imaging Services: Revenue generated from providing nuclear medicine diagnostic imaging services including PET scans and scintigraphy examinations. Services are typically reimbursed through the French national health insurance system (Sécurité Sociale).

Go-to-market motion1 record

Distribution channels3 records

Marketing channels1 record

Core offering

CIMOF is a nuclear medicine imaging center providing PET scan (TEP) and Scintigraphy diagnostic examinations to patients across the Occitanie region of France. The center uses radiotracers such as FDG, Choline, PSMA, F-DOPA, and DOTATOC for oncology, cardiology, neurology, bone, renal, endocrine, and other functional assessments. Services are delivered through five clinical locations and accessed via physician referrals or direct online appointment booking.

Product overview

CIMOF (Centre d'Imagerie Moléculaire et Fonctionnelle) is a nuclear medicine imaging center offering two core diagnostic services: TEP Scan (PET scan) and Scintigraphie (Scintigraphy). The TEP Scan portfolio includes TEP FDG, TEP Choline/PSMA, and TEP F-DOPA/DOTATOC variants for oncology, cardiology, and neurology applications. The Scintigraphy service encompasses multiple specialized explorations including cardiac, bone/joint, pulmonary, endocrine, renal, digestive, lymphatic, and cerebral imaging. CIMOF operates across five locations in the Occitanie region of France, serving patients and referring physicians with diagnostic nuclear medicine examinations.

Differentiator

Problem solved

Functional benefit

Products and services

• TEP Scan (Tomographie par Emission de Positons)

Quantifiable outcome

• No allergies or side effects from nuclear medicine procedures

Named customers5 records

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• GCS Pyrénées TEP (Groupement de Coopération Sanitaire)coreStrategic or Co-development PartnerHealthcare cooperation group comprising Centre Hospitalier de Pau, Centre Hospitalier de Tarbes-Lourdes, and CIMOF for shared PET scan equipment and services. A second PET CT scanner was installed at Centre Hospitalier de Pau as part of this partnership extension, enabling expanded diagnostic capacity across the regional healthcare network.

Scale indicators2 records

Recent moves5 records

Expansion highlights3 records

Others

• GE HealthCare: Global medical imaging equipment manufacturer, including the PET/CT systems CIMOF deploys. Comparable as the underlying technology vendor whose installed base defines CIMOF's service capabilities.
• Siemens Healthineers: Global medical imaging and diagnostics equipment vendor including PET/CT and SPECT systems. Adjacent peer as the alternative equipment ecosystem to GE that competing nuclear medicine centers may use.

Broad incumbents

• Affidea: Pan-European outpatient imaging operator with PET/CT and advanced diagnostic capabilities. Comparable as a multi-site diagnostic imaging services provider targeting hospital and specialist referrals across European regions.
• Alliance Medical: European provider of diagnostic imaging services including PET/CT, with operations across the UK and continental Europe. Comparable as a multi-site, reimbursement-driven nuclear medicine imaging services business.
• Cerba Healthcare: Major French private diagnostic services platform offering imaging and laboratory testing across multiple regions. Comparable to CIMOF as a French private-sector diagnostics provider serving hospital and physician referrals, though broader in scope than CIMOF's nuclear medicine focus.

Direct peers

• Inovie: Large French medical biology and diagnostic imaging network operating multi-site clinics. Direct competitor in the French private outpatient diagnostics market, with overlapping referral-driven business models in southern France.
• C2i Santé: French nuclear medicine and imaging services operator running multiple PET/CT sites in France. Highly comparable to CIMOF in service mix, technology base, and operating model.

Regional players

• Medipole Partners / IM2P: Regional French nuclear medicine and imaging operators active in southern France. Comparable to CIMOF as private regional PET/CT service providers competing for the same Occitanie-area referral base.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/cimof-centre-d-imagerie-mol%C3%A9culaire-et-fonctionnelle

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CIMOF (Centre d'Imagerie MOléculaire et Fonctionnelle)